Obesity dysregulates the pulmonary antiviral immune response
Obesity is a well-recognized risk factor for severe influenza infections but the mechanisms underlying susceptibility are poorly understood. Here, we identify that obese individuals have deficient pulmonary antiviral immune responses in bronchoalveolar lavage cells but not in bronchial epithelial cells or peripheral blood dendritic cells. We show that the obese human airway metabolome is perturbed with associated increases in the airway concentrations of the adipokine leptin which correlated negatively with the magnitude of ex vivo antiviral responses. Exogenous pulmonary leptin administration in mice directly impaired antiviral type I interferon responses in vivo and ex vivo in cultured airway macrophages. Obese individuals hospitalised with influenza showed dysregulated upper airway immune responses. These studies provide insight into mechanisms driving propensity to severe influenza infections in obesity and raise the potential for development of leptin manipulation or interferon administration as novel strategies for conferring protection from severe infections in obese higher risk individuals.
Funding
Wellcome Trust/Imperial College Clinical Research Training Fellowship
MRC Clinician Scientist Fellowship (MR/Y000935/1)
The role of leukotriene A4 hydrolase in dictating inflammation and remodelling in chronic lung diseases
Wellcome Trust
Find out more...Asthma UK Clinical Chair (Grant CH11SJ)
HUMAN AND MOUSE MODELS OF RHINOVIRUS INDUCED ACUTE ASTHMA EXACERBATIONS
European Research Council
Find out more...Elucidating how the respiratory tract microbiota regulate immune responses to bacterial infection
Medical Research Council
Find out more...NIHR Imperial Biomedical Research Centre (BRC)
History
School
- Sport, Exercise and Health Sciences
Published in
Nature CommunicationsVolume
14Publisher
Springer NatureVersion
- VoR (Version of Record)
Rights holder
© The Author(s)Publisher statement
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Acceptance date
2023-10-11Publication date
2023-10-19Copyright date
2023eISSN
2041-1723Publisher version
Language
- en